Affordable Access

Publisher Website

Recent advances in the understanding of the role of the endocannabinoid system in liver diseases

Authors
Journal
Digestive and Liver Disease
1590-8658
Publisher
Elsevier
Publication Date
Volume
43
Issue
3
Identifiers
DOI: 10.1016/j.dld.2010.08.010
Keywords
  • Cannabinoid Receptors
  • Novel Therapeutic Strategies
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Endocannabinoids are ubiquitous signalling molecules that exert their effects through a number of specific cannabinoid receptors. Recent studies have indicated that this endocannabinoid system is involved in the pathophysiological processes associated with both acute and chronic liver diseases as well as in the complications that arise from these diseases such as hepatic encephalopathy and cardiac problems. Targeting this signalling system has been useful in ameliorating some of the symptoms and consequences in experimental models of these liver diseases. This review summarises the recent advances into our knowledge and understanding of endocannabinoids in liver diseases and highlights potential novel therapeutic strategies that may prove useful to treat these diseases.

There are no comments yet on this publication. Be the first to share your thoughts.